Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

December 27, 2012

Ghoodshim v. Isis Pharmaceuticals, Inc. et al

Track this case

Case Number:

3:12-cv-03071

Court:

California Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Cathy Ann Bencivengo

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 02, 2013

    Isis Accused Of Hiding Cholesterol Drug's Safety Risks

    A putative class action launched Friday in California federal court alleges Isis Pharmaceuticals Inc. misled investors over the safety and effectiveness of cholesterol disorder treatment Kynamro, which U.S. Food and Drug Administration researchers warned in October had potentially serious side effects.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login